G. H. Draffan

1.4k total citations
29 papers, 1.1k citations indexed

About

G. H. Draffan is a scholar working on Clinical Biochemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, G. H. Draffan has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Biochemistry, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in G. H. Draffan's work include Metabolism and Genetic Disorders (9 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). G. H. Draffan is often cited by papers focused on Metabolism and Genetic Disorders (9 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). G. H. Draffan collaborates with scholars based in United Kingdom, United States and France. G. H. Draffan's co-authors include R. A. Clare, D. Gompertz, D. S. Davies, M.M. Rhead, C. T. Dollery, Sandra Murray, James A. McCloskey, John L. Reid, Jennifer L. Watts and D. Hull and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

G. H. Draffan

29 papers receiving 945 citations

Peers

Countries citing papers authored by G. H. Draffan

Since Specialization

Citations

This map shows the geographic impact of G. H. Draffan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. H. Draffan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. H. Draffan more than expected).

Fields of papers citing papers by G. H. Draffan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. H. Draffan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. H. Draffan. The network helps show where G. H. Draffan may publish in the future.

Co-authorship network of co-authors of G. H. Draffan

This figure shows the co-authorship network connecting the top 25 collaborators of G. H. Draffan. A scholar is included among the top collaborators of G. H. Draffan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. H. Draffan. G. H. Draffan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	THE PERCUTANEOUS ABSORPTION OF TRIARYLMETHANE AND PHENOXAZINE TYPE COLOUR FORMER COMPONENTS OF CARBONLESS COPY PAPERS <xref ref-type="fn" rid="fn1"><sup></sup></xref> 1986 ·The Annals of Occupational Hygiene* ·Brian Cameron, (unknown), G. H. Draffan, (unknown)	5
2	Quantitative determination of the herbicide paraquat in human plasma by gas chromatographic and mass spectrometric methods 1977 ·Journal of Chromatography A ·G. H. Draffan, R. A. Clare, D. L. Davies, (unknown), Sandra Murray, D. S. Davies	59
3	Clinical pharmacology and pharmacokinetics of clonidine 1976 ·Clinical Pharmacology & Therapeutics ·C. T. Dollery, D. S. Davies, G. H. Draffan, H. J. Dargie, Caron Dean, John L. Reid, R. A. Clare, Sandra Murray	207
4	Plasma concentration of phenylbutazone and its therapeutic effect‐ studies in patients with rheumatoid arthritis. 1976 ·British Journal of Clinical Pharmacology ·M. Orme, P J Holt, G. R. V. Hughes, C J Bulpitt, G. H. Draffan, Thorgeirsson Ss, (unknown), (unknown)	33
5	Pharmacokinetics of indoramin in man. 1976 ·British Journal of Clinical Pharmacology ·G. H. Draffan, (unknown), (unknown), (unknown), C. T. Dollery	21
6	Quantitative determination of the major metabolite of prostaglandins F1α and F2α in human urine by stable isotope dilution and combined gas chromatography-mass spectrometry 1976 ·Biochemical Medicine ·Alan Brash, Thomas A. Baillie, R. A. Clare, G. H. Draffan	31
7	Amylobarbitone Hydroxylation Kinetics in Small Samples of Rat and Human Liver 1976 ·Xenobiotica ·H Fraser, Faith M. Williams, David L. Davies, G. H. Draffan, D. S. Davies	8
8	A New Method for the Determination of the Major Metabolite of Prostaglandin F2α in Human Urine Based on Stable Isotope Dilution and Gas Chromatography-Mass Spectrometry 1976 ·Biochemical Society Transactions ·Alan Brash, G. H. Draffan, R. A. Clare, Thomas A. Baillie	4
9	Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy 1976 ·Clinical Pharmacology & Therapeutics ·G. H. Draffan, C T Dollery, D. S. Davies, (unknown), Frances M. K. Williams, R. A. Clare, Brian Trudinger, Michael Darling, (unknown), D. F. Hawkins	9
10	1 Gas-Liquid Chromatography-Mass Spectrometry in Biochemistry, Pharmacology and Toxicology 1975 ·Progress in medicinal chemistry ·A. M. Lawson, G. H. Draffan	6
11	A defect in l-isoleucine metabolism associated with α-methyl-β-hydroxybutyric and α-methylacetoacetic aciduria: Quantitative in vivo and in vitro studies 1974 ·Clinica Chimica Acta ·D. Gompertz, Jean‐Marie Saudubray, C. Charpentier, K. Bartlett, (unknown), G. H. Draffan	38
12	Alveolar gas concentrations of fluorocarbons-11 and -12 in man after use of pressurized aerosols 1974 ·Thorax ·G. H. Draffan, C. T. Dollery, Frances M. K. Williams, R. A. Clare	5
13	Use of 18F labelled fluorocarbon-11 to investigate the fate of inhaled fluorocarbons in man and in the rat 1974 ·Thorax ·Faith M. Williams, G. H. Draffan, C. T. Dollery, (unknown), Andrew Palmer, Peter Vernon	7
14	Elimination kinetics of amobarbital in mothers and their newborn infants 1973 ·Clinical Pharmacology & Therapeutics ·(unknown), G. H. Draffan, Faith M. Williams, R. A. Clare, C. T. Dollery, D. F. Hawkins	25
15	The gas-chromatographic diagnosis of intermittent maple syrup urine disease (branch-chain ketoaciduria) 1972 ·Clinica Chimica Acta ·D. Gompertz, G. H. Draffan	20
16	Conversion of Oleic Acid to Saturated Fatty Acids in Severn Estuary Sediments 1971 ·Nature ·M.M. Rhead, G. Eglinton, G. H. Draffan, P. England	114
17	Demethylation of 3-O-methyldopa. 1971 ·PubMed ·John Chalmers, D. S. Davies, G. H. Draffan, John L. Reid, S S Thorgeirsson	5
18	Organic Analysis of the Returned Lunar Sample 1970 ·Science ·Paul I. Abell, G. H. Draffan, G. Eglinton, John M. Hayes, James R. Maxwell, C. T. Pillinger	18
19	BLOOD CONCENTRATIONS IN MAN OF FLUORINATED HYDROCARBONS AFTER INHALATION OF PRESSURISED AEROSOLS 1970 ·The Lancet ·C. T. Dollery, D. S. Davies, G. H. Draffan, (unknown), M. E. Conolly	59
20	Electron impact‐induced rearrangement of trimethylsilyl groups in long chain compounds 1968 ·Organic Mass Spectrometry ·G. H. Draffan, R. N. Stillwell, James A. McCloskey	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact